1529 related articles for article (PubMed ID: 28836192)
1. The Bleomycin Model of Pulmonary Fibrosis.
Liu T; De Los Santos FG; Phan SH
Methods Mol Biol; 2017; 1627():27-42. PubMed ID: 28836192
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting Skp2 E3 Ligase Suppresses Bleomycin-Induced Pulmonary Fibrosis.
Mikamo M; Kitagawa K; Sakai S; Uchida C; Ohhata T; Nishimoto K; Niida H; Suzuki S; Nakayama KI; Inui N; Suda T; Kitagawa M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415439
[TBL] [Abstract][Full Text] [Related]
3. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
Lamb YN
Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
[TBL] [Abstract][Full Text] [Related]
4. Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease.
Peng R; Sridhar S; Tyagi G; Phillips JE; Garrido R; Harris P; Burns L; Renteria L; Woods J; Chen L; Allard J; Ravindran P; Bitter H; Liang Z; Hogaboam CM; Kitson C; Budd DC; Fine JS; Bauer CM; Stevenson CS
PLoS One; 2013; 8(4):e59348. PubMed ID: 23565148
[TBL] [Abstract][Full Text] [Related]
5. CXCL6 antibody neutralization prevents lung inflammation and fibrosis in mice in the bleomycin model.
Besnard AG; Struyf S; Guabiraba R; Fauconnier L; Rouxel N; Proost P; Uyttenhove C; Van Snick J; Couillin I; Ryffel B
J Leukoc Biol; 2013 Dec; 94(6):1317-23. PubMed ID: 23975892
[TBL] [Abstract][Full Text] [Related]
6. B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis.
François A; Gombault A; Villeret B; Alsaleh G; Fanny M; Gasse P; Adam SM; Crestani B; Sibilia J; Schneider P; Bahram S; Quesniaux V; Ryffel B; Wachsmann D; Gottenberg JE; Couillin I
J Autoimmun; 2015 Jan; 56():1-11. PubMed ID: 25441030
[TBL] [Abstract][Full Text] [Related]
7. Sphingolipids in pulmonary fibrosis.
Huang LS; Natarajan V
Adv Biol Regul; 2015 Jan; 57():55-63. PubMed ID: 25446881
[TBL] [Abstract][Full Text] [Related]
8. Collagen 1a1 Expression by Airway Macrophages Increases In Fibrotic ILDs and Is Associated With FVC Decline and Increased Mortality.
Tsitoura E; Trachalaki A; Vasarmidi E; Mastrodemou S; Margaritopoulos GA; Kokosi M; Fanidis D; Galaris A; Aidinis V; Renzoni E; Tzanakis N; Wells AU; Antoniou KM
Front Immunol; 2021; 12():645548. PubMed ID: 34867934
[TBL] [Abstract][Full Text] [Related]
9. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
Hyldgaard C
Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
[TBL] [Abstract][Full Text] [Related]
10. Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis.
Vittal R; Mickler EA; Fisher AJ; Zhang C; Rothhaar K; Gu H; Brown KM; Emtiazjoo A; Lott JM; Frye SB; Smith GN; Sandusky GE; Cummings OW; Wilkes DS
PLoS One; 2013; 8(10):e76451. PubMed ID: 24204629
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats.
Li S; Yang X; Li W; Li J; Su X; Chen L; Yan G
Respiration; 2012; 84(6):509-17. PubMed ID: 23006535
[TBL] [Abstract][Full Text] [Related]
12. Persistent, Progressive Pulmonary Fibrosis and Epithelial Remodeling in Mice.
Redente EF; Black BP; Backos DS; Bahadur AN; Humphries SM; Lynch DA; Tuder RM; Zemans RL; Riches DWH
Am J Respir Cell Mol Biol; 2021 Jun; 64(6):669-676. PubMed ID: 33406369
[TBL] [Abstract][Full Text] [Related]
13. Selenite selectively kills lung fibroblasts to treat bleomycin-induced pulmonary fibrosis.
Lin JH; Liu CC; Liu CY; Hsu TW; Yeh YC; How CK; Hsu HS; Hung SC
Redox Biol; 2024 Jun; 72():103148. PubMed ID: 38603946
[TBL] [Abstract][Full Text] [Related]
14. Telomerase and telomere length in pulmonary fibrosis.
Liu T; Ullenbruch M; Young Choi Y; Yu H; Ding L; Xaubet A; Pereda J; Feghali-Bostwick CA; Bitterman PB; Henke CA; Pardo A; Selman M; Phan SH
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):260-8. PubMed ID: 23526226
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of the inhibitor of growth family member 4 (ING4) in different forms of pulmonary fibrosis.
Tzouvelekis A; Aidinis V; Harokopos V; Karameris A; Zacharis G; Mikroulis D; Konstantinou F; Steiropoulos P; Sotiriou I; Froudarakis M; Pneumatikos I; Tringidou R; Bouros D
Respir Res; 2009 Feb; 10(1):14. PubMed ID: 19250543
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of CHIT1 as a novel therapeutic approach in idiopathic pulmonary fibrosis.
Sklepkiewicz P; Dymek BA; Mlacki M; Koralewski R; Mazur M; Nejman-Gryz P; Korur S; Zagozdzon A; Rymaszewska A; von der Thüsen JH; Siwińska AM; Güner NC; Cheda Ł; Paplinska-Goryca M; Proboszcz M; van den Bosch TPP; Górska K; Golab J; Kamiński RM; Krenke R; Golebiowski A; Dzwonek K; Dobrzanski P
Eur J Pharmacol; 2022 Mar; 919():174792. PubMed ID: 35122869
[TBL] [Abstract][Full Text] [Related]
17. VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease.
Barratt SL; Flower VA; Pauling JD; Millar AB
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695053
[TBL] [Abstract][Full Text] [Related]
18. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
[TBL] [Abstract][Full Text] [Related]
19. Oropharyngeal aspiration of bleomycin: An alternative experimental model of pulmonary fibrosis developed in Swiss mice.
Bale S; Sunkoju M; Reddy SS; Swamy V; Godugu C
Indian J Pharmacol; 2016; 48(6):643-648. PubMed ID: 28066100
[TBL] [Abstract][Full Text] [Related]
20. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis.
Sun H; Zhu Y; Pan H; Chen X; Balestrini JL; Lam TT; Kanyo JE; Eichmann A; Gulati M; Fares WH; Bai H; Feghali-Bostwick CA; Gan Y; Peng X; Moore MW; White ES; Sava P; Gonzalez AL; Cheng Y; Niklason LE; Herzog EL
Arthritis Rheumatol; 2016 May; 68(5):1251-61. PubMed ID: 26749424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
